cryptocurrency backed by usd, snippets

Recently, all localities are vigorously promoting mergers and acquisitions, first in Shenzhen and then in Shanghai, and it is estimated that Beijing will soon. The listed companies in the north and Shenzhen are all active, and the merger of Shanghai benchmark brokerage Haitong+Guotai Junan has landed! Other places will follow suit, but mergers and acquisitions are really difficult to grasp, and it is estimated that there are more local+state-owned assets.Shanghai's action plan for mergers and acquisitions is still very strong! Three years to cultivate 10 head companies, forming a scale of 300 billion mergers and acquisitions, which clearly accelerate the merger of securities companies and build a first-class investment bank. This is a semiconductor leader, a pharmaceutical leader, a new material leader, a brokerage leader, etc., which directly benefits Shanghai local stocks and pays attention to Shanghai's advantages. This time, the merger with assets exceeding 2 trillion is clearly activated, which shows great determination.Guoxin Technology: shareholders such as the National Fund intend to reduce their holdings by no more than 3%;

Guoxin Technology: shareholders such as the National Fund intend to reduce their holdings by no more than 3%;First, heavy! Shanghai merger and reorganization action plan announcedIn short, it is the recent big bull stocks that have been announced to reduce their holdings. For example, Yiming Food has 11 consecutive boards, and the price of the world has reached a record high. Zhongyan shares have two 20cm daily limit! They are all popular topics such as AI applications and robots. Many have indeed risen a lot, even to record highs, but the reason is to rub a hot spot. In this case, it is normal for shareholders to reduce their holdings! The human heart is like this, and you can't stop it.

Second, Contemporary Amperex Technology Co., Limited's enlargement trick: special dividends for factories in EuropeHaineng Industry: The controlling shareholder intends to reduce the company's shares by no more than 3%;Among them, the biggest benefit is the biomedical industry. It is necessary to set up a M&A fund with a scale of 10 billion, which is specifically aimed at the merger and reorganization of the biomedical industry! The focus is on local enterprises in Shanghai, especially the biomedicine of listed companies in Shanghai.